Review
Open access
Aug 2026
Rethinking single-pathology therapies by targeting inflammation and co-pathologies in Parkinson’s disease
The known immune response in PD with co-pathology incidence is integrated, highlighting synergistic interactions between α-syn, tau and Aβ and how this promotes a distinct neuroinflammatory response leading to severe neuronal loss and cognitive symptoms.
Jhodi M. Webster, Ashley S. Harms
· npj Parkinson's Disease · 0 citations